Siwei Wang
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- RNA modifications and cancer 9
- Circular RNAs in diseases 4
-
- Cancer-related molecular mechanisms research 10
- Cancer Genomics and Diagnostics 5
- MicroRNA in disease regulation 5
- Co-authors
- Rong Yin (28 shared papers)Lin Xu (23 shared papers)Zhifei Ma (14 shared papers)Chencheng Han (8 shared papers)Panqi Fang (6 shared papers)Tongyan Liu (10 shared papers)Wenjia Xia (17 shared papers)Mantang Qiu (10 shared papers)
- Journals
- Cancer Letters (3 papers)Nature Communications (3 papers)Cancer Communications (2 papers)Clinical and Translational Medicine (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Siwei Wang
66 papers receiving 2.7k citations
Siwei Wang's Hit Papers
Peers
Comparison fields: 5 of 121
- Cancer Research 993
- Oncology 563
- Molecular Biology 1.5k
- Immunology 337
- Pulmonary and Respiratory Medicine 340
Countries citing papers authored by Siwei Wang
This map shows the geographic impact of Siwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siwei Wang more than expected).
Fields of papers citing papers by Siwei Wang
This network shows the impact of papers produced by Siwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siwei Wang. The network helps show where Siwei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Siwei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy Hit paper breakdown → | 2019 | 670 |
| 2 | 2016 | 229 | |
| 3 | 2018 | 215 | |
| 4 | 2017 | 191 | |
| 5 | 2022 | 122 | |
| 6 | 2017 | 115 | |
| 7 | 2024 | 67 | |
| 8 | 2022 | 64 | |
| 9 | 2021 | 62 | |
| 10 | 2018 | 61 | |
| 11 | 2021 | 60 | |
| 12 | 2020 | 58 | |
| 13 | 2022 | 50 | |
| 14 | 2020 | 48 | |
| 15 | 2021 | 43 | |
| 16 | 2016 | 39 | |
| 17 | 2019 | 38 | |
| 18 | 2020 | 38 | |
| 19 | 2023 | 36 | |
| 20 | 2023 | 34 |
About Siwei Wang
Siwei Wang is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery and Immunology, having authored 68 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (9 papers), Cancer Genomics and Diagnostics (5 papers), MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (4 papers), Lung Cancer Treatments and Mutations (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Ferroptosis and cancer prognosis (3 papers). The work is most often cited by research in Cancer Research (993 citations), Oncology (563 citations), Molecular Biology (1.5k citations), Immunology (337 citations) and Pulmonary and Respiratory Medicine (340 citations). Siwei Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Rong Yin, Lin Xu, Zhifei Ma, Chencheng Han, Panqi Fang, Tongyan Liu, Wenjia Xia, Mantang Qiu, Youtao Xu and Gaochao Dong. Their work appears in journals such as Cancer Letters, Nature Communications, Cancer Communications, Clinical and Translational Medicine and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.